| New |
| Code |
Description |
| A4435 |
Ostomy pouch, drainable, high output, with extended wear barrier (one-piece system), with or without filter, each |
| G0458 |
Low dose rate (ldr) prostate brachytherapy services, composite rate |
| J0485 |
Injection, belatacept, 1 mg |
| J0890 |
Injection, peginesatide, 0. 1 mg (for esrd on dialysis) |
| J7527 |
Everolimus, oral, 0. 25 mg |
| L7902 |
Tension ring, for vacuum erection device, any type, replacement only, each |
| G9229 |
Chlamydia, gonorrhea, and syphilis not screened, due to documented reason (patient refusal is the only allowed exclusion) |
| G9231 |
Documentation of end stage renal disease (esrd), dialysis, renal transplant or pregnancy |
| G9239 |
Documentation of reasons for patient initiaiting maintenance hemodialysis with a catheter as the mode of vascular access (eg, patient has a maturing avf/avg, time-limited trial of hemodialysis, patients undergoing palliative dialysis, other medical reasons, patient declined avf/avg, other patient reasons, patient followed by reporting nephrologist for fewer than 90 days, other system reasons) |
| G9264 |
Documentation of patient receiving maintenance hemodialysis for greater than or equal to 90 days with a catheter for documented reasons (eg, patient is undergoing palliative dialysis with a catheter, patient approved by a qualified transplant program and scheduled to receive a living donor kidney transplant, other medical reasons, patient declined avf/avg, other patient reasons) |
| G9503 |
Patient taking tamsulosin hydrochloride |
| G9523 |
Patient discontinued from hemodialysis or peritoneal dialysis |
| G9606 |
Intraoperative cystoscopy performed to evaluate for lower tract injury |
| G9607 |
Patient is not eligible (e.g., patient death during procedure, absent urethra or an otherwise inaccessible bladder) |
| G9608 |
Intraoperative cystoscopy not performed to evaluate for lower tract injury |
| G9625 |
Patient sustained bladder injury at the time of surgery or subsequently up to 1 month post-surgery |
| G9626 |
Patient is not eligible (e.g., gynecologic or other pelvic malignancy documented, concurrent surgery involving bladder neoplasia or otherwise to treat a bladder specific problem, patient death from other causes, etc.) |
| G9627 |
Patient did not sustained bladder injury at the time of surgery or subsequently up to 1 month post-surgery |
| G9632 |
Patient is not eligible (e.g., gynecologic or other pelvic malignancy documented, concurrent surgery involving bladder neoplasia or otherwise to treat a bladder specific problem, patient death from other causes, etc.) |
| G9633 |
Patient did not sustain ureter injury at the time of surgery or subsequently up to 1 month post-surgery |
| J1443 |
Injection, ferric pyrophosphate citrate solution, 0.1 mg of iron |
| J2407 |
Injection, oritavancin, 10 mg |
| J7503 |
Tacrolimus, extended release, (Envarsus XR), oral, 0.25 mg |
| C9483 |
Injection, atezolizumab, 10 mg |
| G0491 |
Dialysis procedure at a medicare certified esrd facility for acute kidney injury without esrd |
| G0492 |
Dialysis procedure with single evaluation by a physician or other qualified health care professional for acute kidney injury without esrd |
| G9684 |
This code is for the onsite acute care treatment of a nursing facility resident for a uti; may only be billed once per day per beneficiary |
| G9722 |
Documented history of renal failure or baseline serum creatinine = 4.0 mg/dl; renal transplant recipients are not considered to have preoperative renal failure, unless, since transplantation the cr has been or is 4.0 or higher |
| G9747 |
Patient is undergoing palliative dialysis with a catheter |
| G9748 |
Patient approved by a qualified transplant program and scheduled to receive a living donor kidney transplant |
| G9749 |
Patient is undergoing palliative dialysis with a catheter |
| G9750 |
Patient approved by a qualified transplant program and scheduled to receive a living donor kidney transplant |
| C9016 |
Injection, triptorelin extended release, 3.75 mg |
| C9738 |
Adjunctive blue light cystoscopy with fluorescent imaging agent (list separately in addition to code for primary procedure) |
| C9748 |
Transurethral destruction of prostate tissue; by radiofrequency water vapor (steam) thermal therapy |
| G9894 |
Androgen deprivation therapy prescribed/administered in combination with external beam radiotherapy to the prostate |
| G9895 |
Documentation of medical reason(s) for not prescribing/administering androgen deprivation therapy in combination with external beam radiotherapy to the prostate (e.g., salvage therapy) |
| G9896 |
Documentation of patient reason(s) for not prescribing/administering androgen deprivation therapy in combination with external beam radiotherapy to the prostate |
| G9897 |
Patients who were not prescribed/administered androgen deprivation therapy in combination with external beam radiotherapy to the prostate, reason not given |
| J0604 |
Cinacalcet, oral, 1 mg, (for esrd on dialysis) |
| J0606 |
Injection, etelcalcetide, 0.1 mg |
